STRATA Skin Sciences, Inc. (SSKN)
OTCMKTS
· Delayed Price · Currency is USD
0.130
+0.008 (6.56%)
At close: Apr 28, 2026
STRATA Skin Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 30.7 | 33.56 | 33.36 | 36.16 | 29.98 | Upgrade
|
| Revenue Growth (YoY) | -8.54% | 0.61% | -7.75% | 20.63% | 29.83% | Upgrade
|
| Cost of Revenue | 12.82 | 14.34 | 14.9 | 14.39 | 10.13 | Upgrade
|
| Gross Profit | 17.88 | 19.22 | 18.46 | 21.77 | 19.85 | Upgrade
|
| Selling, General & Admin | 23.3 | 23.33 | 23.46 | 25.39 | 22.82 | Upgrade
|
| Research & Development | 0.42 | 0.88 | 1.32 | 1.03 | 1.43 | Upgrade
|
| Operating Expenses | 23.72 | 24.21 | 24.78 | 26.42 | 24.25 | Upgrade
|
| Operating Income | -5.84 | -4.99 | -6.32 | -4.65 | -4.4 | Upgrade
|
| Interest Expense | -1.96 | -2.11 | -1.64 | -0.93 | -0.31 | Upgrade
|
| Interest & Investment Income | 0.41 | 0.24 | 0.23 | 0.09 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -7.38 | -6.85 | -7.73 | -5.49 | -4.7 | Upgrade
|
| Impairment of Goodwill | - | -4.27 | -2.28 | - | - | Upgrade
|
| Other Unusual Items | 1.14 | 0.86 | -0.91 | - | 2.03 | Upgrade
|
| Pretax Income | -6.25 | -10.26 | -10.92 | -5.49 | -2.67 | Upgrade
|
| Income Tax Expense | 0.01 | -0.17 | -0.09 | 0.06 | 0.03 | Upgrade
|
| Net Income | -6.26 | -10.09 | -10.83 | -5.55 | -2.71 | Upgrade
|
| Net Income to Common | -6.26 | -10.09 | -10.83 | -5.55 | -2.71 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 4 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 22.15% | 9.03% | 0.60% | 1.94% | 1.31% | Upgrade
|
| EPS (Basic) | -1.35 | -2.65 | -3.10 | -1.60 | -0.79 | Upgrade
|
| EPS (Diluted) | -1.35 | -2.65 | -3.10 | -1.60 | -0.79 | Upgrade
|
| Free Cash Flow | -4.26 | -1.45 | -5.54 | -4.66 | -2.15 | Upgrade
|
| Free Cash Flow Per Share | -0.92 | -0.38 | -1.59 | -1.34 | -0.63 | Upgrade
|
| Gross Margin | 58.25% | 57.27% | 55.34% | 60.20% | 66.22% | Upgrade
|
| Operating Margin | -19.01% | -14.86% | -18.95% | -12.86% | -14.69% | Upgrade
|
| Profit Margin | -20.40% | -30.05% | -32.47% | -15.35% | -9.03% | Upgrade
|
| Free Cash Flow Margin | -13.88% | -4.31% | -16.60% | -12.89% | -7.16% | Upgrade
|
| EBITDA | -1.71 | -0.02 | -0.77 | 0.64 | -0.67 | Upgrade
|
| EBITDA Margin | -5.58% | -0.06% | -2.30% | 1.78% | -2.22% | Upgrade
|
| D&A For EBITDA | 4.12 | 4.97 | 5.55 | 5.29 | 3.74 | Upgrade
|
| EBIT | -5.84 | -4.99 | -6.32 | -4.65 | -4.4 | Upgrade
|
| EBIT Margin | -19.01% | -14.86% | -18.95% | -12.86% | -14.68% | Upgrade
|
| Advertising Expenses | 0.8 | 1 | 0.5 | 1.6 | 1.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.